Topical nepafenac inhibits ocular neovascularization.
Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA.
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):409-15.PMID: 12506103 [PubMed - indexed for MEDLINE]Related articlesFree article